|
Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From …
CNNMoney … Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today the issuance of approximately 10.1 million of its shares of common stock pursuant to the exercise of A-Warrants originally … |
